Former NHS Chief Pharmaceutical Negotiator, Blake Dark, joins Newmarket Strategy

Newmarket Strategy announced the appointment of Blake Dark as a Senior Partner. Blake joined Newmarket full time on 1 March as the company celebrated two years of success.

Until November 2022, Dark was the NHS’s Chief Negotiator with the pharmaceutical industry and was Interim Chief Commercial Officer and member of NHS England’s Executive Committee.

Blake will augment the firm’s offer to global pharmaceutical companies and healthcare systems on innovation and commercial strategy.

At NHS England Blake led several high-profile deals for cutting-edge new medicines including three gene therapies, multiple oncology products and personalised medicines. He delivered first of a kind innovative procurements for NHS patients such as Hepatitis C, AMR subscription model, GRAIL agreement and Inclisiran population health programmes in the UK.

Prior to joining the NHS, Blake held senior roles in the pharmaceutical industry, including 25 years at Sanofi, where he was Head of Global Commercial Operations for Sanofi’s generics company and managed Sanofi branded innovative businesses across multiple European countries.

Newmarket Strategy’s leaders have decades of experience in health innovation delivery. Our expertise covers healthcare, life sciences and healthtech across the bench-to-bedside value chain.